Study Shows Gene Variations May Predict Risk of Breast Cancer in WomenMay 05, 2008According to a recent study, led by Virginia Kaklamani, MD, an oncologist at Northwestern Memorial Hospital and assistant professor of medicine, Northwestern University Feinberg School of Medicine, variations of the adiponectin gene, which regulates a number of metabolic processes, may increase a woman's risk of developing breast cancer. This discovery is an important step forward in cancer genetics research, as it could help experts develop a future genetic testing model to more accurately predict a woman's risk of developing breast cancer. Dr. Kaklamani's research, which is published in the May 1 issue of Cancer Research, suggests some women are born with different characteristics in the adiponectin gene which can alter its function and increase the risk of breast cancer. This finding, coupled with previous studies that have found a correlation between low levels of adiponectin in the body and cancer risk, suggest adiponectin may be the third gene linked to breast cancer among women with no previous family history of breast cancer. If confirmed through additional studies, adiponectin could be used along with TGF-beta and CHEK2, genes that have already been linked to breast cancer, to create a genetic testing model that will allow clinicians to more accurately predict breast cancer risk. Clinicians currently rely on epidemiologic models to predict breast cancer risk. The most common is the GAIL model, which looks at a number of factors including a woman's current age, the age she began menstruating, her age at menopause, age of first live birth, previous biopsies and family history. "All we know is that one in eight women will get breast cancer somehow, for some reason," says Dr. Kaklamani. "One explanation for this is genetic background, and the adiponectin gene is one that may be responsible. By pinpointing which genes are associated with breast cancer risk, we can better predict risk, and ultimately may be able to enhance efforts for breast cancer prevention," adds Kaklamani. Genetic testing is already being used among women with a strong family history of breast cancer to determine if the BRCA genes are present, which have been linked to hereditary breast cancer. However, the vast majority of women diagnosed with breast cancer each year do not have familial breast cancer, leaving a large number of breast cancers unexplained.
"With further research and testing, our hope is that some day all women may be able to proactively test their genetic risk for breast cancer. By doing so, those found to have a high risk could work with their physician to take preventative measures that may lower their risk and aid in early detection, such as having frequent mammograms and undergoing a breast MRI," said Kaklamani. "This is still in the distant future, however each day researchers take one step closer," adds Kaklamani. Northwestern Memorial | |||||||||||||||||||||
|
Related Breast Cancer News Articles New ovarian stimulation technique offers more cancer patients the chance to preserve their fertility Researchers have shown for the first time that it is possible to stimulate a woman's ovaries to produce eggs for collection during the final phase of the menstrual cycle. Should embryos with a hereditary disorder be transferred if no unaffected embryos are available? The numbers of cycles of preimplantation genetic diagnosis or screening are rising steadily in Europe with over 2,700 reported in 2004 (the most recent year for which data are available). Overweight, insulin resistant women at greater risk of advanced breast cancer diagnosis, says study Women who have risk factors commonly associated with Type 2 diabetes also have much greater odds of being diagnosed with an advanced breast cancer. 98 percent of elective mastectomy patients would have reconstruction again, says ASPS study Women who have breast reconstruction after an elective mastectomy are satisfied with their decision, have low complication rates and 98 percent would do it again. Treatment delays result in poor outcomes for men with breast cancer Men who develop breast cancer are often not treated until the disease has spread to the point that treatment becomes difficult, new results show. Researchers identify cancer preventive properties in common vitamin supplement Early laboratory research has shown that resveratrol, a common dietary supplement, suppresses the abnormal cell formation that leads to most types of breast cancer, suggesting a potential role for the agent in breast cancer prevention. Cancer 'cure' in mice to be tested in humans Scientists at Wake Forest University Baptist Medical Center are about to embark on a human trial to test whether a new cancer treatment will be as effective at eradicating cancer in humans as it has proven to be in mice. Heavy birthweight babies twice as likely to develop rheumatoid arthritis Heavy birthweight female babies are twice as likely to develop rheumatoid arthritis in adulthood as their average birthweight peers, suggests research published ahead of print in the Annals of the Rheumatic Diseases. Pregnancy may help protect against bladder cancer Pregnancy seems to confer some protection against bladder cancer in mice, scientists have found. Laser Surgery Probe Targets Individual Cancer Cells Mechanical engineering Assistant Professor Adela Ben-Yakar at The University of Texas at Austin has developed a laser "microscalpel" that destroys a single cell while leaving nearby cells intact, which could improve the precision of surgeries for cancer, epilepsy and other diseases. More Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||